CALGARY, Alberta, Nov. 06, 2025 (GLOBE NEWSWIRE) -- TransAlta Corporation (TransAlta or the Company) (TSX: TA) (NYSE: TAC) today reported its financial results for the third quarter ended Sept. 30, 2025. “Our business delivered solid operational performance during the third quarter, demonstrating the Company's resilience in the face of challenging market conditions. Our Alberta portfolio's hedging strategy and active asset optimization continued to generate realized prices well above spot prices, while avai ...

PEMGARDA® (pemivibart) net product revenue of $13.1 million reported for Q3 2025, representing 41% growth year-over-year and 11% growth quarter-over-quarterOctober 2025 ending cash and cash equivalents of over $100 million; ended Q3 2025 with $85.0 million in cash and cash equivalents after closing of $57.5 million public offering in August 2025, with additional $29.8 million gross proceeds from usage of at-the-market (ATM) offering facility in October 2025Announced U.S. IND clearance and alignment with U.S ...

NASHVILLE, Tenn., Nov. 06, 2025 (GLOBE NEWSWIRE) -- First Atlantic Nickel Corp. (“First Atlantic or the “Company”) (TSXV: FAN) (OTCQB: FANCF) (FSE: P21) is pleased to announce its participation at the North American Stainless & Special Alloys Conference 2025, taking place November 6-7, 2025, in Nashville, Tennessee. The Company will participate in business development discussions throughout the event, showcasing how its Pipestone XL Nickel Alloy Project addresses the growing need for nickel, cobalt and chro ...

NASHVILLE, Tenn., Nov. 06, 2025 (GLOBE NEWSWIRE) -- First Atlantic Nickel Corp. (“First Atlantic or the “Company”) (TSXV: FAN) (OTCQB: FANCF) (FSE: P21) is pleased to announce its participation at the North American Stainless & Special Alloys Conference 2025, taking place November 6-7, 2025, in Nashville, Tennessee. The Company will participate in business development discussions throughout the event, showcasing how its Pipestone XL Nickel Alloy Project addresses the growing need for nickel, cobalt and chro ...

JPMorgan lowered the firm’s price target on Live Nation (LYV) to $172 from $180 and keeps an Overweight rating on the shares following the fiscal Q2 report. The firm believes the impact from secondary ticketing changes is less than what was priced into the shares. Live Nation’s demand indicators remain strong, with continued growth in onsite spending and event deferred revenue up 37%, the analyst tells investors in a research note. Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help ...

AppLovin ( APP ) released another strong quarter, which means that my previous calls questioning sustainability of growth and operating leverage did not age well. The share price is currentlyWith a decade at a Big 4 audit firm specializing in the banking, mining, and energy sectors, I bring a strong foundation in finance and strategy. Currently, I serve as the Head of Finance for a leading owner and operator of retail real estate, where I oversee complex financial operations and strategy. I’ve been an activ ...

JPMorgan raised the firm’s price target on Shopify (SHOP) to $180 from $179 and keeps an Overweight rating on the shares. The firm cites positive estimate revisions post the earnings report for the target bump. Shopify’s volume growth accelerated sequentially in Q3, but a spike in transaction losses weighed on the Q4 free cash flow margin outlook, the analyst tells investors in a research note. JPMorgan points out that Shopify has not seen a material change in intra-quarter spend trends while the increase ...

文章核心观点 - 前总统特朗普致信17家制药公司CEO，要求其降低药品价格以减轻消费者负担，否则将进行干预 [1] - 美国消费者为治疗常见疾病的药物支付的价格高于其他国家消费者 [1] 美国市场高销售额药品分析 - 默克公司Keytruda（用于多种癌症）每3周一次剂量价格为11,795美元，2024年全球销售额为295亿美元 [3][5] - 诺和诺德公司Ozempic（用于2型糖尿病）每周注射笔价格为997.58美元（28天供应），但近90%有保险的患者实际支付金额低于25美元，2024年销售额超过170亿美元 [7] - 礼来公司Mounjaro（用于糖尿病、减肥）28天供应（4支注射笔）价格约为1,080美元，2024年全球销售额为115亿美元 [9][10] - 百时美施贵宝/辉瑞公司Eliquis（用于抗凝血）每月费用为500-600美元，2024年销售额为114亿美元 [12] - 吉利德科学公司Biktarvy（用于HIV）每月费用为2,000-3,000美元，2024年销售额为100亿美元 [14]

Camden Property Trust is expected to report a 3.1% increase in revenues, reaching approximately $398 million.The company's core funds from operations (FFO) per share are anticipated to decline by 1.17%, settling at $1.69.Despite revenue growth, new supply in the market could pressure rental growth, impacting Camden's financial performance.Camden Property Trust (NYSE:CPT) is a real estate investment trust (REIT) that focuses on the ownership, management, and development of multifamily apartment communities. ...

Press ReleaseNokia Bell Labs and KDDI Research unite to drive innovation in 6G energy efficiency and network resiliency These two industry-leading research institutions are expanding their collaboration efforts to advance 6G technologies, setting the foundation for transformative connectivity solutions.The research collaboration will enable the commercialization of 6G networks that prioritize energy efficiency and resiliency. 6 November 2025Espoo, Finland – Nokia and KDDI Research have entered into a joint ...